RADIOPHARM ORDINARY (RAD) Short Interest
RADIOPHARM ORDINARY (ASX:RAD) had 0.03% of shares reported as short positions as of 16 July 2026, representing 943,859 shares. RADIOPHARM ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Radiopharm Theranostics
Radiopharm Theranostics is a clinical-stage radiotherapeutics company focused on developing a pipeline of first-in-class radiopharmaceuticals for the diagnosis and treatment of cancer. The company aims to transform cancer care by delivering innovative solutions for earlier detection and personalized treatment of cancers with unmet needs.
Short position
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4RAD intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Radiopharm Theranostics
Latest RAD news
All news- Radiopharm Theranostics (ASX:RAD) Progresses Pipeline with Multiple Clinical Milestones
kalkine
- Radiopharm Receives $5.9M R&D Tax Incentive
asx
- Radiopharm Theranostics (ASX:RAD): Why Are ASX Penny Stocks Facing a Catalyst Test?
kalkine
- Notification regarding unquoted securities - RAD
asx
- Notification of cessation of securities - RAD
asx
About
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss RAD
Start a research thread or post the first pulse update